Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2
- 324 Downloads
Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a naturally occurring flavonoid which is widely distributed in plants. It has been reported to possess some anticancer and anti-invasive capabilities. We set out to explore the effects of fisetin on antimetastatic and its mechanism of action in GBM8401 cells. The results indicated that fisetin exhibited effective inhibition of cell migration and inhibited the invasion of GBM8401 cells under non-cytotoxic concentrations. To identify the potential targets of fisetin, human proteinase antibody array analysis was performed, and the results indicated that the fisetin treatment inhibited the expression of ADAM9 protein and mRNA, which are known to contribute to the progression of glioma cancer. Our results showed that fisetin phosphorylated ERK1/2 in a sustained way that contributed to the inhibited ADAM9 protein and mRNA expression determined by Western blot and RT-PCR. Moreover, inhibition of ERK1/2 by U0126 or transfection with the siERK plasmid significantly abolished the fisetin-inhibited migration and invasion through activation of the ERK1/2 pathway. In summary, our results suggest that fisetin might be a potential therapeutic agent against human glioma cells based on its capacity to activate ERK1/2 and to inhibit ADAM9 expression.
KeywordsGlioma cancer cells Fisetin Migration Invasion ADAM9
This work was supported by grants from Chung Shan Medical University (CSMU-INT-102-15) and Chung Shan Medical University and Changhua Christian Hospital, Changhua, Taiwan (CSMU-CCH-103-02).
Conflicts of interest
- 15.Husmann K, Arlt MJ, Muff R, Langsam B, Bertz J, et al. Matrix metalloproteinase-1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochim Biophys Acta. 1832;2013:347–54.Google Scholar
- 22.Tsai JP, Hsiao PC, Yang SF, Hsieh SC, Bau DT, et al. Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-kappaB-mediated urokinase plasminogen activator expression. PLoS One. 2014;9:e86537.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and activator protein-1-dependent monocyte networks. J Immunol. 2010;184:6492–503.CrossRefPubMedGoogle Scholar
- 36.Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 1802;2010:396–405.Google Scholar
- 42.Chen YY, Liu FC, Chou PY, Chien YC, Chang WS, et al. Ethanol extracts of fruiting bodies of Antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways. Evid Based Complement Alternat Med. 2012;378415Google Scholar
- 47.Veit C, Genze F, Menke A, Hoeffert S, Gress TM, et al. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res. 2004;1–5300.Google Scholar
- 49.Hanai J, Doro N, Sasaki AT, Kobayashi S, Cantley LC, et al. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways. J Cell Physiol. 2012;227:1709–20.CrossRefPubMedPubMedCentralGoogle Scholar